Laboratorios Farma | ROVI - Cost Of Sales


Laboratorios Farma reported EUR186.09M in Cost of Sales for its fiscal semester ending in December of 2023.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Almirall EUR 199.26M 7.76M Jun/2026
Avita Medical AUD 3.3M 166K Dec/2025
Ionis Pharmaceuticals USD 2.74M 261K Jun/2026
IQVIA Holdings USD 3.22B 141M Jun/2026
Laboratorios Farma EUR 186.09M 11.06M Dec/2023
Moderna USD 93M 862M Jun/2026
Organon & Co USD 711M 34M Jun/2026
Pharma Mar EUR 4.73M 1.08M Jun/2026
Revvity USD 312.82M 10.64M Jun/2026
Viatris USD 2.3B 59.5M Jun/2026
Xeris Pharmaceuticals USD 10.57M 3.08M Mar/2026